PRO MEDICUS LIMITED (PME)



Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!


General Information
Company Name: Pro Medicus Limited
Stock Code: PME
Website: www.promedicus.com.au
GICS Sub-Industry: Health Care Distributors
Market Cap ($M): 46
Equiv. Shares (M): 100

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
$ 0.460 $ 0.460 $ 0.460 $ 0.460 $ 0.460 400 0%

Current Broker Consensus Recommendation more
Recommendation: Hold
Recommendation Date: 2nd Sep 2009
12 Month Target Price (average): $0.85
Brokers Surveyed: 1

Company Overview

Business Description:
Pro Medicus Limited (PME) is a provider of integrated software applications and IT solutions and services including training and installation, hardware configuration and ongoing technical and end user support to the private healthcare industry. PME has geographical presence in Australia, North America and Europe.


Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2012  A 0.8 0.8 60.0 14.9 1.5 5.6 100.0
2011  A 0.5 0.5 -87.2 86.2 0.0 0.0 --
2010  A 3.9 3.9 -31.6 18.3 2.0 2.8 100.0
Source: Aspect actuals / Thomson IBES estimates

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2010 A 2011 F 2012 F 2010 A 2011 F 2012 F 2010 A 2011 F 2012 F
Pro Medicus (PME) $46 M 0.5000 -- -- 25.6983 -- -- 0.0326 -- --
Primary Health Care (PRY) $2,504 M 0.1146 0.2739 0.1208 21.3030 16.7227 14.9204 0.0221 0.0282 0.0315
Sonic Healthcare (SHL) $5,495 M 0.0688 0.0475 0.0439 17.1499 16.3729 15.6845 0.0426 0.0434 0.0461
Sigma Pharma. (SIP) $891 M 0.4047 -0.1695 0.0857 13.2203 15.9184 14.6617 0.0513 0.0551 0.0606

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
PME 0.94 25.7 2.88 -- 4.10
Market 0.94 12.3 0.82 1.92 2.44
Sector 0.84 21.6 2.73 2.69 1.84

Directors
Name Position Start Date
Dr Sam Aaron Hupert Chief Executive Officer,Managing Director 01 January 1983
Mr Anthony Barry Hall Executive Director,Technology Director 01 January 1983
Mr Peter Terence Kempen Non-Executive Chairman 12 March 2008
Mr Roderick L.J Lyle Non-Executive Director 23 November 2010

Management
Name Position
Clayton Hatch Chief Financial Officer,Company Secretary
Danny Tauber General Manager - Pro Medicus Limited
Brad Levin General Manager - Visage Imaging Inc
Malte Westerhoff Managing Director - Visage Imaging GmbH

Substantial Shareholders
Holding Name
30,068,500 (29.98%) Hall, Anthony Barry
6,204,080 (6.19%) Commonwealth Bank Group
30,072,660 (29.99%) Sam Aaron Hupert
10,619,255 (10.59%) Perpetual Limited RBC Dexia Investor Services Australia Nominees P/L

Calendar of Events
Date Event
21 February 2014 Report (Interim)
16 October 2013 Report (Annual)
23 August 2013 Report (Prelim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.

Advertisement

Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Investment Fees

An educational booklet to help you find out everything you must know about investment fees.

More details...

News

Market recovery rides a big dipper

The Age 19/06/2013 | The bullish sentiments on the sharemarket earlier this year have been challenged by a correction that has taken the All Ordinaries Index down about 10 per cent from its May highs. Many investors are now asking how deep the current correction is likely to be.

Be prudent and don't take the market at face value

The Age 19/06/2013 | Done well, value investing is a successful, safe way to invest. The logic of the approach - buying an asset for less than its underlying value - is irrefutable.

Go for broke - insolvency can be the best solution

The Age 19/06/2013 | Snowballing debts and no means to repay them ... going bankrupt is the last-ditch option for those in a financial hole too deep to climb out from.

Often overlooked, micro caps are offering value

The Age 19/06/2013 | One of the weapons an individual has over institutions is time, and with real value emerging at the micro-cap end of the market, smaller stocks are an area worth holding on to.

Sun rises once more on Japan

The Age 19/06/2013 | Spending 10 days in Japan gives one a good overview of what they call "Abenomics" and its impact, and that includes also being here for one of the biggest drops on the Japanese market in weeks.

No rally after Lend Lease reassurance

The Age 19/06/2013 | Lend Lease has moved to allay investors' concerns with the issue of a formal profit guidance of between $540 million and $550 million for the full year, despite the weakness in the construction sector.

More...


Sponsored Links

Feedback Form